Stanford's Cancer Facilities

Stanford’s cancer facilities emphasize the need for collaboration in order to produce the best new research and treatments for cancer.

			The Division of Oncology is headquartered in the Center for Clinical Sciences Research, popularly known as the CCSR. CCSR walkways give an open feel to the building, and bridges unite research units physically and symbolically. Oncology labs occupy the first floor of the CCSR building.

The Center for Clinical Sciences Research (CCSR)

The Division of Oncology’s administrative offices, research laboratories, and research faculty are housed in The Center for Clinical Sciences Research. State-of-the-art laboratories and core facilities reflect the private philanthropic commitments of more than $77 million which provided funding for the project. The most advanced research facilities and equipment enable researchers to produce and safety-test materials to be administered to patients in human clinical trials and to analyze cells from patients to monitor the effects of treatment in real time.

By its physical layout, the CCSR, completed in May, 2000, integrates scientists from several departments around three major interdisciplinary, interdepartmental programs - cancer biology and cancer therapy, immunology and transplantation, and genetics and gene therapy - creating the critical mass of new ideas that is essential to scientific advancement.

The Center for Clinical Sciences Research houses four major investigative centers:

• The Center for Cancer Research includes distinguished scientists from multiple disciplines and forms the anchor program for the new building.
• The Center for Clinical Immunology pursues applications of immunological research in the treatment of diseases as diverse as juvenile-onset diabetes, rheumatoid arthritis, asthma, multiple sclerosis, systematic lupus erythematusus, acquired immune deficiency syndrome, and many cancers.
• The Center for Applied Human Genetics focuses on developing genetic therapies that will reach across the spectrum of human diseases from single-gene disorders to genetically complex systemic diseases such as atherosclerosis and cancer.
• The Department of Molecular Pharmacology studies the basic mechanisms of a variety of diseases and the therapeutic uses of drugs.

The Stanford Cancer Center

The Division’s clinical research is conducted in the Stanford Cancer Center.

The clinical facility, which debuted early in 2004, offers patients with cancer and other medical conditions a modern, welcoming facility in which to receive outpatient care. In bright corridors and exam rooms, patients and their families find a positive and healing environment. The building’s interior design is rich in color and detail and incorporates specially selected artwork. Indoor fountains and gardens provide a serene environment where patients and families can gather. The new building accommodates the growing demand for outpatient services, offering patients simpler, less invasive options for care.

			The Stanford Cancer Center combines outpatient treatment and clinical research in a multimodality setting.

Most of Stanford’s cancer services are consolidated in this building, fostering a team approach and enabling patients to stay in one location for procedures and tests. The building brings together members of Stanford’s renowned clinical faculty, a professional interaction crucial to the pursuit of new medical knowledge and to the design of well-coordinated treatment plans. The development of improved equipment and technologies delivers the most advanced cancer therapies and speed the transfer of research discoveries to the clinic, where they can be made available to patients through clinical trials.

The structure houses a radiation therapy site, a mammography and diagnostic radiology unit, multimodality cancer clinics, a treatment unit, a learning center, social services, nutritional services, a tumor registry, a pharmacy, an academic and clinical research site, a conference center, and other components of a comprehensive cancer center. The cancer-related sites occupy about 60% of the facility, or two and a half floors. The remainder of the structure is given over to ambulatory care services.